<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00152646</url>
  </required_header>
  <id_info>
    <org_study_id>PHRC 04-07</org_study_id>
    <nct_id>NCT00152646</nct_id>
  </id_info>
  <brief_title>Platelets Induced Vasodilation, in Vitro and in Vivo Study</brief_title>
  <official_title>Platelets Induced Vasodilation, in Vitro and in Vivo Study in Patients With Arteriopathy and Healthy Subjects.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Angers</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Angers</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of the study is to show the implication of platelets in vasodilation using in vivo&#xD;
      and in vitro analysis and to compare the effects of placebo, aspirin and Clopidogrel in this&#xD;
      interaction platelets/vessels.&#xD;
&#xD;
      The effects of 7 days of each treatment will be compared in healthy subjects and patients&#xD;
      with arteriopathy.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>March 2005</start_date>
  <completion_date type="Anticipated">January 2008</completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double</masking>
  </study_design_info>
  <primary_outcome>
    <measure>In vivo vasodilation induced by low intensity current</measure>
  </primary_outcome>
  <primary_outcome>
    <measure>In vitro study of platelets function</measure>
  </primary_outcome>
  <primary_outcome>
    <measure>In vitro vasodilation induced by platelets in isolated rat's vessels</measure>
  </primary_outcome>
  <enrollment type="Anticipated">36</enrollment>
  <condition>Peripheral Arterial Disease</condition>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>placebo, aspirine, clopidogrel</intervention_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
        Inclusion criteria healthy subjects&#xD;
&#xD;
          -  Man or Woman 18 years&#xD;
&#xD;
          -  Agreement signed&#xD;
&#xD;
          -  French health insurance&#xD;
&#xD;
          -  Able to understand the study&#xD;
&#xD;
          -  Biological haemostatic test normal&#xD;
&#xD;
          -  Vascular Doppler of lower limbs normal&#xD;
&#xD;
          -  Pressure index &gt; 1 in both lower limbs&#xD;
&#xD;
        Inclusion criteria healthy subjects&#xD;
&#xD;
          -  Man or Woman 18 years&#xD;
&#xD;
          -  Agreement signed&#xD;
&#xD;
          -  French health insurance&#xD;
&#xD;
          -  Able to understand the study&#xD;
&#xD;
          -  Biological haemostatic test normal&#xD;
&#xD;
          -  Lower limbs arteriopathy (clinical, pressure index, Doppler)&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Unable to sign agreement&#xD;
&#xD;
          -  Subjects protected by low&#xD;
&#xD;
          -  Participation to other study&#xD;
&#xD;
          -  Changes of treatment within the 15 days before inclusion&#xD;
&#xD;
          -  Chronic treatment with Clopidogrel or drugs against inflammation&#xD;
&#xD;
          -  Severe respiratory, cardiac, kidney, hepatic insufficiency&#xD;
&#xD;
          -  Haemostatic troubles&#xD;
&#xD;
          -  Diabetic neuropathy&#xD;
&#xD;
          -  Neurologic desease (Parkinsonâ€¦..)&#xD;
&#xD;
          -  Hypertension&#xD;
&#xD;
          -  Symptomatic stomach ulcer&#xD;
&#xD;
          -  Anaemia Hb&lt;11g/l&#xD;
&#xD;
          -  Pregnant women or breast feeding&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Marc Antoine Custaud, MD PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital, Angers</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Exploration Fonctionnelles Vasculaires</name>
      <address>
        <city>Angers</city>
        <state>Maine et Loire</state>
        <zip>49933</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Marc Antoine Custaud, MD PhD</last_name>
      <phone>33241353689</phone>
      <email>macustaud@chu-angers.fr</email>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>September 2005</verification_date>
  <study_first_submitted>September 7, 2005</study_first_submitted>
  <study_first_submitted_qc>September 7, 2005</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 9, 2005</study_first_posted>
  <last_update_submitted>February 3, 2010</last_update_submitted>
  <last_update_submitted_qc>February 3, 2010</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 4, 2010</last_update_posted>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Peripheral Arterial Disease</mesh_term>
    <mesh_term>Peripheral Vascular Diseases</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Clopidogrel</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

